Overview
Solstice Oncology, a Boston, MA-based immuno-oncology company focused on treating cancer earlier in the neoadjuvant setting, raised $225M in Series A financing. The round was led by RA Capital Management with participation from Canaan Partners, Forbion and other investors....See more
Website
https://www.solsticeoncology.com/Headquarters
Boston, MA
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$225.0M • Series A
Announced on 9/9/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.